{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:29:07Z","timestamp":1773322147568,"version":"3.50.1"},"reference-count":29,"publisher":"BMJ","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Genet"],"published-print":{"date-parts":[[1998,12]]},"abstract":"<jats:p>Patients who present with unilateral vestibular schwannomas either at a young age or with additional features of type 2 neurofibromatosis (NF2) are at risk of developing bilateral disease and transmitting a risk of neurogenic tumours to their offspring. We have identified 15 patients from a series of 537 with unilateral vestibular schwannomas who also had one or more of the following: other tumours (10\/15), features of NF2 (3\/15), or a family history of neurogenic tumours (5\/15). No germline NF2 mutations were detected and in 7\/9 cases where tumour material was available for analysis a germline mutation in the NF2 gene has been excluded. Although a possibility of gonosomal mosaicism still exists, exclusion tests for the offspring are now possible. We suggest a general strategy, based on analysis of tumour DNA, for distinguishing sporadic and familial cases of tumours caused by two hit mechanisms. Application of this strategy suggests that most instances of unilateral vestibular schwannoma which do not fulfil criteria for NF2 represent chance occurrences.<\/jats:p>","DOI":"10.1136\/jmg.35.12.973","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T15:37:21Z","timestamp":1226331441000},"page":"973-977","source":"Crossref","is-referenced-by-count":20,"title":["Differential diagnosis of type 2 neurofibromatosis: molecular discrimination of NF2 and sporadic vestibular schwannomas."],"prefix":"10.1136","volume":"35","author":[{"given":"C L","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Thakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Neary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Lye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R T","family":"Ramsden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A P","family":"Read","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D G","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1998,12,1]]},"reference":[{"key":"ref_1","first-page":"851","article-title":"Central neurofibromatosis with bilateral acoustic neuroma. Genetic, clinical and biochemical distinctions from peripheral neurofibromatosis","volume":"301","author":"Kanter, W.R.; Eldridge, R.; Fabricant, R.; Allen, J.C.; Koerber, T.","year":"1980","unstructured":"Kanter WR, Eldridge R, Fabricant R, Allen JC, Koerber T. Central neurofibromatosis with bilateral acoustic neuroma. Genetic, clinical and biochemical distinctions from peripheral neurofibromatosis. Neurology 1980;301:851-9.","journal-title":"Neurology"},{"key":"ref_2","first-page":"603","article-title":"A clinical study of type 2 neurofibromatosis","volume":"84","author":"Evans, D.G.R.; Huson, S.M.; Donnai, D.","year":"1992","unstructured":"Evans DGR, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Q Med 1992;84:603-18.","journal-title":"Q Med"},{"key":"ref_3","first-page":"4501","article-title":"Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity","volume":"52","author":"Parry, D.M.; Eldridge, R.; Kaiser-Kupfer, M.I.; Bouzas, E.A.; Pikus, A.; Patronas, N.","year":"1994","unstructured":"Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 1994;52:4501.","journal-title":"Am J Med Genet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1017\/S002221510012328X","article-title":"Type 2 neurofibromatosis: the need for supraregional care","volume":"107","author":"Evans, D.G.R.; Ramsden, R.; Huson, S.M.","year":"1993","unstructured":"Evans DGR, Ramsden R, Huson SM, et al. Type 2 neurofibromatosis: the need for supraregional care. Laryngol Otol 1993;107:401-6.","journal-title":"Laryngol Otol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson, A.G.","year":"1971","unstructured":"Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref_6","article-title":"Mosaicism in classical NF2: a common mechanism for sporadic disease in tumour prone syndromes?","author":"Evans, D.G.R.; Trueman, L.; Wallace, A.; Wu, C.L.; Strachan, T.","unstructured":"Evans DGR, Trueman L, Wallace A, Wu CL, Strachan T. Mosaicism in classical NF2: a common mechanism for sporadic disease in tumour prone syndromes? Am. Hum Genet (in press).","journal-title":"Am. Hum Genet"},{"key":"ref_7","first-page":"78","article-title":"Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred. NEngl!","volume":"319","author":"Wertelecki, W.; Rouleau, G.A.; Superneau, D.W.","year":"1988","unstructured":"Wertelecki W, Rouleau GA, Superneau DW, et al. Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred. NEngl!JMed 1988;319:78-83.","journal-title":"JMed"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2","volume":"363","author":"Rouleau, G.A.; Merel, P.; Lutchman, M.","year":"1993","unstructured":"Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993;363: 515-21.","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","article-title":"A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor","volume":"72","author":"Troffater, J.A.; MacCollin, M.; Rutter, J.L.","year":"1993","unstructured":"Troffater JA, MacCollin M, Rutter JL, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993;72:791-800.","journal-title":"Cell"},{"key":"ref_10","first-page":"314","article-title":"Mutational analysis of patients with neurofibromatosis 2","volume":"55","author":"MacCollin, M.; Ramesh, V.; Jacoby, L.B.","year":"1994","unstructured":"MacCollin M, Ramesh V, Jacoby LB, et al. Mutational analysis of patients with neurofibromatosis 2. Am 7 Hum Genet 1994;55:314-20.","journal-title":"Am 7 Hum Genet"},{"key":"ref_11","first-page":"813","article-title":"Germline mutations in the neurofibromatosis type 2 tumour suppressor gene","volume":"5","author":"Bourn, D.; Carter, S.A.; Mason, S.; Evans, D.G.R.; Strachan, T.","year":"1994","unstructured":"Bourn D, Carter SA, Mason S, Evans DGR, Strachan T. Germline mutations in the neurofibromatosis type 2 tumour suppressor gene. Hum Mol Genet 1994;5:813-16.","journal-title":"Hum Mol Genet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/gcc.2870120206","article-title":"Screening for germline mutations in the NF2 gene","volume":"12","author":"Merel, P.; Hoang-Xuan, K.; Sansom, M.","year":"1995","unstructured":"Merel P, Hoang-Xuan K, Sansom M, et al. Screening for germline mutations in the NF2 gene. Genes Chrom Cancer 1995;12:117-27.","journal-title":"Genes Chrom Cancer"},{"key":"ref_13","first-page":"529","article-title":"Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities","volume":"59","author":"Parry, D.M.; MacCollin, M.; Kaiser-Kupfer, M.I.","year":"1996","unstructured":"Parry DM, MacCollin M, Kaiser-Kupfer MI, et al. Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. AmJ'Hum Genet 1996;59:529-39.","journal-title":"AmJ'Hum Genet"},{"key":"ref_14","first-page":"331","article-title":"Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease","volume":"59","author":"Ruttledge, M.H.; Andermann, A.A.; Phelan, C.M.","year":"1996","unstructured":"Ruttledge MH, Andermann AA, Phelan CM, et al. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet 1996;59:331-42.","journal-title":"Am J Hum Genet"},{"key":"ref_15","first-page":"634","article-title":"A clinical, genetic and audiological study of patients with type 2 neurofibromatosis. I. Clinical features of neurofibromatosis in patients with unilateral vestibular schwannomas","volume":"107","author":"Neary, W.; Newton, V.E.; Laiode-Kemp, S.N.","year":"1993","unstructured":"Neary W, Newton VE, Laiode-Kemp SN, et al. A clinical, genetic and audiological study of patients with type 2 neurofibromatosis. I. Clinical features of neurofibromatosis in patients with unilateral vestibular schwannomas. J Laryngol Otol 1993;107:634-40.","journal-title":"J Laryngol Otol"},{"key":"ref_16","first-page":"6484","article-title":"Read AP, Harris R, Thakker NS. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity","volume":"54","author":"Wu, C.L.; Sloan, P.","year":"1994","unstructured":"Wu CL, Sloan P, Read AP, Harris R, Thakker NS. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Res 1994;54:6484-8.","journal-title":"Cancer Res"},{"key":"ref_17","first-page":"2766","article-title":"Detection of polymorphisms of human DNA by gel electrophoresis","volume-title":"as single-strand conformation polymorphisms. Proc NatlAcad Sci USA","volume":"86","author":"Orita, M.; Iwahana, H.; Kanazawa, H.; Hayashi, K.; Sekiya, T.","year":"1989","unstructured":"Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc NatlAcad Sci USA 1989;86:2766-70."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/hmg\/3.3.413","article-title":"Exon scanning for mutation of the NF2 gene in schwannomas","volume":"3","author":"Jacoby, L.B.; MacCollin, M.; Louis, D.N.","year":"1994","unstructured":"Jacoby LB, MacCollin M, Louis DN, et al. Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 1994;3:413-19.","journal-title":"Hum Mol Genet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jmg.30.11.951","article-title":"Non-isotopic analysis of single strand conformation polymorphism (SSCP) in the exon 13 region of the human dystrophin gene","volume":"30","author":"Lenke, U.; Hanke, R.; Kraft, U.; Grade, I.; Grunewald, I.; Speer, A.","year":"1993","unstructured":"Lenke U, Hanke R, Kraft U, Grade I, Grunewald I, Speer A. Non-isotopic analysis of single strand conformation polymorphism (SSCP) in the exon 13 region of the human dystrophin gene. J Med Genet 1993;30:951-4.","journal-title":"J Med Genet"},{"key":"ref_20","first-page":"712","article-title":"Highly polymorphic dinucleotide repeat at the NF2 locus","volume":"95","author":"Bourn, D.; Strachan, T.","year":"1995","unstructured":"Bourn D, Strachan T. Highly polymorphic dinucleotide repeat at the NF2 locus. Hum Genet 1995;95:712.","journal-title":"Hum Genet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ng0694supp-246","article-title":"The 1993-4 Genethon human genetic linkage map","volume":"7","author":"Gyapay, G.; Morisette, J.; Vignal, A.","year":"1994","unstructured":"Gyapay G, Morisette J, Vignal A, et al. The 1993-4 Genethon human genetic linkage map. Nat Genet 1994;7: 246-339.","journal-title":"Nat Genet"},{"key":"ref_22","first-page":"6061","article-title":"Loss of heterozygosity of chromosome 8 microsatellite loci implicated a candidate tumour suppressor gene between the loci D8S87 and D8S133 in human prostate cancer","volume":"54","author":"Trapman, J.; Sleddens, H.F.B.M.; van der Weiden, M.M.","year":"1994","unstructured":"Trapman J, Sleddens HFBM, van der Weiden MM, et al. Loss of heterozygosity of chromosome 8 microsatellite loci implicated a candidate tumour suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res 1994;54:6061-4.","journal-title":"Cancer Res"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/jmg.29.12.847","article-title":"A genetic study of type 2 neurofibromatosis. II. Guidelines for genetic counselling","volume":"29","author":"Evans, D.G.R.; Huson, S.M.; Donnai, D.","year":"1992","unstructured":"Evans DGR, Huson SM, Donnai D, et al. A genetic study of type 2 neurofibromatosis. II. Guidelines for genetic counselling. 7 Med Genet 1992;29:847-52.","journal-title":"7 Med Genet"},{"key":"ref_24","first-page":"3","article-title":"Health Consensus Development Conference Statement on Neurofibromatosis","volume":"3","author":"National Institutes of","year":"1987","unstructured":"National Institutes of Health Consensus Development Conference Statement on Neurofibromatosis. Neurofibromarosis Res Newsl 1987;3:3-6.","journal-title":"Neurofibromarosis Res Newsl"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1017\/S0022215100147292","article-title":"Epidemiology of acoustic neuromas","volume":"98","author":"Tos, M.; Thomsen, J.","year":"1984","unstructured":"Tos M, Thomsen J. Epidemiology of acoustic neuromas. J Laryngol Otol 1984;98:685-92.","journal-title":"J Laryngol Otol"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/jmg.29.12.841","article-title":"A genetic study of type 2 neurofibromatosis in the north west of England and the UK. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity","volume":"29","author":"Evans, D.G.R.; Huson, S.M.; Donnai, D.","year":"1992","unstructured":"Evans DGR, Huson SM, Donnai D, et al. A genetic study of type 2 neurofibromatosis in the north west of England and the UK. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 1992;29:841-6.","journal-title":"J Med Genet"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/hmg\/3.2.347","article-title":"Somatic gene mutations in familial and non-familial vestibular schwannoma","volume":"3","author":"Irving, R.M.; Moffat, D.A.; Hardy, D.G.; Barton, D.E.; Xuereb, J.H.; Maher, E.R.","year":"1994","unstructured":"Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER. Somatic gene mutations in familial and non-familial vestibular schwannoma. Hum Mol Genet 1994;3:347-50.","journal-title":"Hum Mol Genet"},{"key":"ref_28","first-page":"211","article-title":"Patterns of risk of hereditary retinoblastoma and applications to genetic counselling. BrJ7 Cancer","volume":"66","author":"Draper, G.J.; Sanders, B.M.; Brownbill, P.A.; Hawkins, M.M.","year":"1992","unstructured":"Draper GJ, Sanders BM, Brownbill PA, Hawkins MM. Patterns of risk of hereditary retinoblastoma and applications to genetic counselling. BrJ7 Cancer 1992;66:211-19."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1227\/00006123-198201000-00001","article-title":"Bilateral acoustic neuromas: clinical aspects, pathogenesis and treatment","volume":"10","author":"Martuza, R.L.; Ojemann, R.G.","year":"1982","unstructured":"Martuza RL, Ojemann RG. Bilateral acoustic neuromas: clinical aspects, pathogenesis and treatment. Neurosurgery 1982;10: 1-12.","journal-title":"Neurosurgery"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg.35.12.973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:48:52Z","timestamp":1760730532000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg.35.12.973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[1998,12,1]]},"published-print":{"date-parts":[[1998,12]]}},"alternative-id":["10.1136\/jmg.35.12.973"],"URL":"https:\/\/doi.org\/10.1136\/jmg.35.12.973","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12]]}}}